Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Pialoux

Showing results (111-120 of 135) with videos related to

Pageof 14
Sort By:
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancyJ B Pain, M P Lê, M Caseris, et al.
AIDS (London, England)|June 27, 2001
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteersG Pialoux, H Gahéry-Ségard, S Sermet, et al.
Journal De Mycologie Medicale|May 2, 2013
[Comment on this case report]G Belkadi, G Buot, Y Senghor, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2008
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004C Larsen, G Pialoux, D Salmon, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
AIDS Research and Human Retroviruses|March 1, 1995
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDAG Pialoux, J L Excler, Y Rivière, et al.
Clinical and Experimental Immunology|November 13, 2001
CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAARTD Scott-Algara, J P Aboulker, C Durier, et al.
Kidney International|March 16, 2007
Nephropathy associated with the diffuse infiltrative lymphocytosis syndromeL Zafrani, P Coppo, S Dettwiler, et al.
Case Reports in Medicine|September 2, 2009
Recurrent bacteremia, a complication of cyanoacrylate injection for variceal bleeding: report of two cases and review of the literatureT Galperine, C Flateau, M D Venon, et al.
Pageof 14

Showing results (111-120 of 135) with videos related to

Sort By:
Pageof 14
Journal of Virology|January 22, 2000
Multiepitopic B- and T-cell responses induced in humans by a human immunodeficiency virus type 1 lipopeptide vaccineH Gahéry-Ségard, G Pialoux, B Charmeteau, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2015
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancyJ B Pain, M P Lê, M Caseris, et al.
AIDS (London, England)|June 27, 2001
Lipopeptides induce cell-mediated anti-HIV immune responses in seronegative volunteersG Pialoux, H Gahéry-Ségard, S Sermet, et al.
Journal De Mycologie Medicale|May 2, 2013
[Comment on this case report]G Belkadi, G Buot, Y Senghor, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|September 3, 2008
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004C Larsen, G Pialoux, D Salmon, et al.
AIDS (London, England)|June 6, 2000
Efficacy and safety of combination therapy with interferon-alpha2b and ribavirin for chronic hepatitis C in HIV-infected patientsA Landau, D Batisse, J P Duong Van Huyen, et al.
AIDS Research and Human Retroviruses|March 1, 1995
A prime-boost approach to HIV preventive vaccine using a recombinant canarypox virus expressing glycoprotein 160 (MN) followed by a recombinant glycoprotein 160 (MN/LAI). The AGIS Group, and l'Agence Nationale de Recherche sur le SIDAG Pialoux, J L Excler, Y Rivière, et al.
Clinical and Experimental Immunology|November 13, 2001
CD4 T cell recovery is slower in patients experiencing viral load rebounds during HAARTD Scott-Algara, J P Aboulker, C Durier, et al.
Kidney International|March 16, 2007
Nephropathy associated with the diffuse infiltrative lymphocytosis syndromeL Zafrani, P Coppo, S Dettwiler, et al.
Case Reports in Medicine|September 2, 2009
Recurrent bacteremia, a complication of cyanoacrylate injection for variceal bleeding: report of two cases and review of the literatureT Galperine, C Flateau, M D Venon, et al.
Pageof 14